The SARS-CoV-2 vaccine developed by the University of Oxford has shown an encouraging immune response in older adults, according to preliminary findings published in The Lancet.
Related Posts
The SARS-CoV-2 vaccine developed by the University of Oxford has shown an encouraging immune response in older adults, according to preliminary findings published in The Lancet.